Copyright Reports & Markets. All rights reserved.

COVID-19 Impact on Global Isocitrate Dehydrogenase Inhibitors Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Isocitrate Dehydrogenase Inhibitors Revenue
  • 1.4 Market Analysis by Type
    • 1.4.1 Global Isocitrate Dehydrogenase Inhibitors Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 IDH1 Mutant Medullary Malignant Tumor
    • 1.4.3 IDH2 Mutant Medullary Malignant Tumor
    • 1.4.4 Others
  • 1.5 Market by Application
    • 1.5.1 Global Isocitrate Dehydrogenase Inhibitors Market Share by Application: 2020 VS 2026
    • 1.5.2 DH Inhibitor
    • 1.5.3 FLT3 Inhibitor
    • 1.5.4 Hedgehog Pathway Inhibitor
    • 1.5.5 Others
  • 1.6 Coronavirus Disease 2019 (Covid-19): Isocitrate Dehydrogenase Inhibitors Industry Impact
    • 1.6.1 How the Covid-19 is Affecting the Isocitrate Dehydrogenase Inhibitors Industry
      • 1.6.1.1 Isocitrate Dehydrogenase Inhibitors Business Impact Assessment - Covid-19
      • 1.6.1.2 Supply Chain Challenges
      • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
    • 1.6.2 Market Trends and Isocitrate Dehydrogenase Inhibitors Potential Opportunities in the COVID-19 Landscape
    • 1.6.3 Measures / Proposal against Covid-19
      • 1.6.3.1 Government Measures to Combat Covid-19 Impact
      • 1.6.3.2 Proposal for Isocitrate Dehydrogenase Inhibitors Players to Combat Covid-19 Impact
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Global Growth Trends by Regions

  • 2.1 Isocitrate Dehydrogenase Inhibitors Market Perspective (2015-2026)
  • 2.2 Isocitrate Dehydrogenase Inhibitors Growth Trends by Regions
    • 2.2.1 Isocitrate Dehydrogenase Inhibitors Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Isocitrate Dehydrogenase Inhibitors Historic Market Share by Regions (2015-2020)
    • 2.2.3 Isocitrate Dehydrogenase Inhibitors Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Isocitrate Dehydrogenase Inhibitors Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Isocitrate Dehydrogenase Inhibitors Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Isocitrate Dehydrogenase Inhibitors Players by Market Size
    • 3.1.1 Global Top Isocitrate Dehydrogenase Inhibitors Players by Revenue (2015-2020)
    • 3.1.2 Global Isocitrate Dehydrogenase Inhibitors Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Isocitrate Dehydrogenase Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Isocitrate Dehydrogenase Inhibitors Market Concentration Ratio
    • 3.2.1 Global Isocitrate Dehydrogenase Inhibitors Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Isocitrate Dehydrogenase Inhibitors Revenue in 2019
  • 3.3 Isocitrate Dehydrogenase Inhibitors Key Players Head office and Area Served
  • 3.4 Key Players Isocitrate Dehydrogenase Inhibitors Product Solution and Service
  • 3.5 Date of Enter into Isocitrate Dehydrogenase Inhibitors Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

  • 4.1 Global Isocitrate Dehydrogenase Inhibitors Historic Market Size by Type (2015-2020)
  • 4.2 Global Isocitrate Dehydrogenase Inhibitors Forecasted Market Size by Type (2021-2026)

5 Isocitrate Dehydrogenase Inhibitors Breakdown Data by Application (2015-2026)

  • 5.1 Global Isocitrate Dehydrogenase Inhibitors Market Size by Application (2015-2020)
  • 5.2 Global Isocitrate Dehydrogenase Inhibitors Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Isocitrate Dehydrogenase Inhibitors Market Size (2015-2020)
  • 6.2 Isocitrate Dehydrogenase Inhibitors Key Players in North America (2019-2020)
  • 6.3 North America Isocitrate Dehydrogenase Inhibitors Market Size by Type (2015-2020)
  • 6.4 North America Isocitrate Dehydrogenase Inhibitors Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Isocitrate Dehydrogenase Inhibitors Market Size (2015-2020)
  • 7.2 Isocitrate Dehydrogenase Inhibitors Key Players in Europe (2019-2020)
  • 7.3 Europe Isocitrate Dehydrogenase Inhibitors Market Size by Type (2015-2020)
  • 7.4 Europe Isocitrate Dehydrogenase Inhibitors Market Size by Application (2015-2020)

8 China

  • 8.1 China Isocitrate Dehydrogenase Inhibitors Market Size (2015-2020)
  • 8.2 Isocitrate Dehydrogenase Inhibitors Key Players in China (2019-2020)
  • 8.3 China Isocitrate Dehydrogenase Inhibitors Market Size by Type (2015-2020)
  • 8.4 China Isocitrate Dehydrogenase Inhibitors Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Isocitrate Dehydrogenase Inhibitors Market Size (2015-2020)
  • 9.2 Isocitrate Dehydrogenase Inhibitors Key Players in Japan (2019-2020)
  • 9.3 Japan Isocitrate Dehydrogenase Inhibitors Market Size by Type (2015-2020)
  • 9.4 Japan Isocitrate Dehydrogenase Inhibitors Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Isocitrate Dehydrogenase Inhibitors Market Size (2015-2020)
  • 10.2 Isocitrate Dehydrogenase Inhibitors Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Isocitrate Dehydrogenase Inhibitors Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Isocitrate Dehydrogenase Inhibitors Market Size by Application (2015-2020)

11 India

  • 11.1 India Isocitrate Dehydrogenase Inhibitors Market Size (2015-2020)
  • 11.2 Isocitrate Dehydrogenase Inhibitors Key Players in India (2019-2020)
  • 11.3 India Isocitrate Dehydrogenase Inhibitors Market Size by Type (2015-2020)
  • 11.4 India Isocitrate Dehydrogenase Inhibitors Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Isocitrate Dehydrogenase Inhibitors Market Size (2015-2020)
  • 12.2 Isocitrate Dehydrogenase Inhibitors Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Isocitrate Dehydrogenase Inhibitors Market Size by Type (2015-2020)
  • 12.4 Central & South America Isocitrate Dehydrogenase Inhibitors Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 AGIOS
    • 13.1.1 AGIOS Company Details
    • 13.1.2 AGIOS Business Overview and Its Total Revenue
    • 13.1.3 AGIOS Isocitrate Dehydrogenase Inhibitors Introduction
    • 13.1.4 AGIOS Revenue in Isocitrate Dehydrogenase Inhibitors Business (2015-2020))
    • 13.1.5 AGIOS Recent Development
  • 13.2 Aslan Pharmaceuticals
    • 13.2.1 Aslan Pharmaceuticals Company Details
    • 13.2.2 Aslan Pharmaceuticals Business Overview and Its Total Revenue
    • 13.2.3 Aslan Pharmaceuticals Isocitrate Dehydrogenase Inhibitors Introduction
    • 13.2.4 Aslan Pharmaceuticals Revenue in Isocitrate Dehydrogenase Inhibitors Business (2015-2020)
    • 13.2.5 Aslan Pharmaceuticals Recent Development
  • 13.3 Bayer
    • 13.3.1 Bayer Company Details
    • 13.3.2 Bayer Business Overview and Its Total Revenue
    • 13.3.3 Bayer Isocitrate Dehydrogenase Inhibitors Introduction
    • 13.3.4 Bayer Revenue in Isocitrate Dehydrogenase Inhibitors Business (2015-2020)
    • 13.3.5 Bayer Recent Development
  • 13.4 Beigene
    • 13.4.1 Beigene Company Details
    • 13.4.2 Beigene Business Overview and Its Total Revenue
    • 13.4.3 Beigene Isocitrate Dehydrogenase Inhibitors Introduction
    • 13.4.4 Beigene Revenue in Isocitrate Dehydrogenase Inhibitors Business (2015-2020)
    • 13.4.5 Beigene Recent Development
  • 13.5 Bristol-Myers Squibb
    • 13.5.1 Bristol-Myers Squibb Company Details
    • 13.5.2 Bristol-Myers Squibb Business Overview and Its Total Revenue
    • 13.5.3 Bristol-Myers Squibb Isocitrate Dehydrogenase Inhibitors Introduction
    • 13.5.4 Bristol-Myers Squibb Revenue in Isocitrate Dehydrogenase Inhibitors Business (2015-2020)
    • 13.5.5 Bristol-Myers Squibb Recent Development
  • 13.6 Celgene
    • 13.6.1 Celgene Company Details
    • 13.6.2 Celgene Business Overview and Its Total Revenue
    • 13.6.3 Celgene Isocitrate Dehydrogenase Inhibitors Introduction
    • 13.6.4 Celgene Revenue in Isocitrate Dehydrogenase Inhibitors Business (2015-2020)
    • 13.6.5 Celgene Recent Development
  • 13.7 Daiichi Sankyo
    • 13.7.1 Daiichi Sankyo Company Details
    • 13.7.2 Daiichi Sankyo Business Overview and Its Total Revenue
    • 13.7.3 Daiichi Sankyo Isocitrate Dehydrogenase Inhibitors Introduction
    • 13.7.4 Daiichi Sankyo Revenue in Isocitrate Dehydrogenase Inhibitors Business (2015-2020)
    • 13.7.5 Daiichi Sankyo Recent Development
  • 13.8 Philogen S.p.A.
    • 13.8.1 Philogen S.p.A. Company Details
    • 13.8.2 Philogen S.p.A. Business Overview and Its Total Revenue
    • 13.8.3 Philogen S.p.A. Isocitrate Dehydrogenase Inhibitors Introduction
    • 13.8.4 Philogen S.p.A. Revenue in Isocitrate Dehydrogenase Inhibitors Business (2015-2020)
    • 13.8.5 Philogen S.p.A. Recent Development
  • 13.9 Tesaro
    • 13.9.1 Tesaro Company Details
    • 13.9.2 Tesaro Business Overview and Its Total Revenue
    • 13.9.3 Tesaro Isocitrate Dehydrogenase Inhibitors Introduction
    • 13.9.4 Tesaro Revenue in Isocitrate Dehydrogenase Inhibitors Business (2015-2020)
    • 13.9.5 Tesaro Recent Development
  • 13.10 Tragara/Adastra
    • 13.10.1 Tragara/Adastra Company Details
    • 13.10.2 Tragara/Adastra Business Overview and Its Total Revenue
    • 13.10.3 Tragara/Adastra Isocitrate Dehydrogenase Inhibitors Introduction
    • 13.10.4 Tragara/Adastra Revenue in Isocitrate Dehydrogenase Inhibitors Business (2015-2020)
    • 13.10.5 Tragara/Adastra Recent Development
  • 13.11 Tocagen
    • 10.11.1 Tocagen Company Details
    • 10.11.2 Tocagen Business Overview and Its Total Revenue
    • 10.11.3 Tocagen Isocitrate Dehydrogenase Inhibitors Introduction
    • 10.11.4 Tocagen Revenue in Isocitrate Dehydrogenase Inhibitors Business (2015-2020)
    • 10.11.5 Tocagen Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    This report focuses on the global Isocitrate Dehydrogenase Inhibitors status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Isocitrate Dehydrogenase Inhibitors development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

    The key players covered in this study
    AGIOS
    Aslan Pharmaceuticals
    Bayer
    Beigene
    Bristol-Myers Squibb
    Celgene
    Daiichi Sankyo
    Philogen S.p.A.
    Tesaro
    Tragara/Adastra
    Tocagen

    Market segment by Type, the product can be split into
    IDH1 Mutant Medullary Malignant Tumor
    IDH2 Mutant Medullary Malignant Tumor
    Others
    Market segment by Application, split into
    DH Inhibitor
    FLT3 Inhibitor
    Hedgehog Pathway Inhibitor
    Others

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    The study objectives of this report are:
    To analyze global Isocitrate Dehydrogenase Inhibitors status, future forecast, growth opportunity, key market and key players.
    To present the Isocitrate Dehydrogenase Inhibitors development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
    To strategically profile the key players and comprehensively analyze their development plan and strategies.
    To define, describe and forecast the market by type, market and key regions.

    In this study, the years considered to estimate the market size of Isocitrate Dehydrogenase Inhibitors are as follows:
    History Year: 2015-2019
    Base Year: 2019
    Estimated Year: 2020
    Forecast Year 2020 to 2026
    For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

    Buy now